Related Experiment Videos
[Erythrocyte filterability and treatment with pentoxifylline]
La Ricerca in Clinica E in Laboratorio
|January 1, 1983
Summary
Pentoxifylline treatment significantly improved erythrocyte filtration rate in patients with insulin-dependent diabetes mellitus and diabetic angiopathy. This suggests potential benefits for tissue oxygen uptake in this patient group.
Area of Science:
- Vascular Medicine
- Endocrinology
- Pharmacology
Background:
- Insulin-dependent diabetes mellitus (IDDM) and diabetic angiopathy often lead to impaired microcirculation.
- Reduced erythrocyte filtration rate is a marker of vascular dysfunction in diabetic patients.
Purpose of the Study:
- To investigate the effect of pentoxifylline on erythrocyte filtration rate in patients with IDDM and diabetic angiopathy.
- To assess the impact of pentoxifylline on tissue oxygen uptake.
Main Methods:
- A randomized, placebo-controlled trial involving twenty patients with IDDM and diabetic angiopathy.
- Patients received either pentoxifylline (1,200 mg/day for 30 days) or a placebo.
Main Results:
- Pentoxifylline treatment led to a statistically significant decrease in erythrocyte filtration rate.
- A significant difference in erythrocyte filtration rate was observed between the pentoxifylline and placebo groups.
Conclusions:
- Pentoxifylline effectively improves erythrocyte filtration rate in patients with diabetic angiopathy.
- The findings suggest pentoxifylline may enhance tissue oxygen uptake by improving microcirculation in diabetic patients.